Browse Our Resources

Learn How IPM.ai is Redefining the Ideal Patient

 

Real World Insights

IPM.ai Uncovers 47% of New Patients for AVEO Oncology’s FOTIVDA®

By: Nitin Choudhary, EVP & GM, IPM.ai

Introduction

For rare and specialty oncology, low incidence rates complicate...

IPM.ai Expands Its Data Universe with Specialty Pharmacy and Payer Master Enhancements

By: Nitin Choudhary, EVP & GM, IPM.ai

IPM.ai is pleased to announce that it has expanded its data universe of over 300...

Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology

By: John Seaner, CMO, IPM.ai/Swoop

Ganesh Rajaratnam, Senior Director of Commercial Operations, Insights & Analytics at...

IPM.ai Recognized as One of the World’s Most Innovative Companies in 2022 by Fast Company

IPM.ai’s transformative approach to patient-finding for specialty and rare conditions captures the #2 spot in the data...

Ron Elwell, CEO and Founder of IPM.ai Wins MM+M’s Pinnacle Award

By: John Seaner, CMO, IPM.ai/Swoop

Ron Elwell, CEO and founder of IPM.ai is a proud recipient of MM+M’s Pinnacle Award....

Utilizing Augmented Intelligence to Drive Optimal Decisions Throughout the Specialty and Rare Disease Product Lifecycle

By: John Seaner, CMO, IPM.ai/Swoop

Life sciences and healthcare companies that set out to pioneer treatments in rare...

More posts

 

Webinars

 

Download Our Case Studies and Publications